CD79B and B-cell chronic lymphocytic leukemia: A total of six surface antigens (CD62L, CD54, CD49c, CD49d, CD38, and CD79b) and prognostic risk models were put in place to diagnose and predict the OS for CLL (Zucchetto et al., 2006).